Product image of Isopto-Maxidex (Dexamethasone) supplied by GNH India

Isopto-Maxidex

Active Ingredient:
Dexamethasone
Origin:
EU

Isopto-Maxidex (Dexamethasone)

Dexamethasone, the active ingredient in Isopto-Maxidex, is a glucocorticoid presented as a 0.1% w/v ophthalmic suspension for ocular use. It reduces inflammation in postoperative eyes, uveitis, allergic conjunctivitis and other inflammatory eye conditions, providing targeted therapy for patients requiring corticosteroid eye drops and is indicated for short‑term management of ocular inflammation to preserve visual function.

GNH India supplies Isopto-Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on consistent potency and safety.

Manufacturer / TM Owner

Novartis Sverige Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Isopto-Maxidex (dexamethasone) is a glucocorticoid ophthalmic suspension used to manage inflammatory eye conditions.

  • Post‑operative ocular inflammation: reduces swelling and pain after eye surgery.
  • Uveitis: controls intra‑ocular inflammation and prevents tissue damage.
  • Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergens.

How It Works

  • Dexamethasone binds to intracellular glucocorticoid receptors, altering gene transcription to suppress phospholipase A2 activity and reduce production of prostaglandins, leukotrienes, and inflammatory cytokines, thereby diminishing ocular inflammation and stabilising cellular membranes.

Side Effects

Isopto-Maxidex may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Eye irritation: transient burning or stinging after instillation.
  • Increased intraocular pressure: mild rise detectable on routine exams.
  • Blurred vision: temporary reduction in visual clarity.
  • Conjunctival hyperemia: mild redness of the eye.

Serious or Rare Side Effects

  • Severe ocular hypertension: significant pressure increase requiring treatment.
  • Secondary glaucoma: optic nerve damage due to pressure elevation.
  • Infectious keratitis: corneal infection that may threaten vision.
  • Hypersensitivity reaction: swelling, rash, or anaphylaxis.

Precautions & Warnings

When prescribing Isopto-Maxidex, clinicians should observe several precautions to minimize risks.

  • Assess intraocular pressure: baseline measurement before initiating therapy.
  • Limit duration: use the lowest effective dose for the shortest period.
  • Monitor for infection: avoid use in active ocular infections unless necessary.
  • Caution in glaucoma patients: may exacerbate pressure elevation.
  • Avoid contact lens wear: remove lenses before and after instillation.
  • Store at room temperature: keep below 25°C, protect from moisture and light in original container.

Avoid Interactions

Isopto-Maxidex can interact with other ocular or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid)

  • Systemic corticosteroids: additive systemic glucocorticoid effects.
  • Anticholinergic eye drops: may reduce drug absorption.
  • CYP3A4 inhibitors (e.g., ketoconazole eye drops): increase local dexamethasone levels.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory eye drops: potential additive irritation.
  • Antiviral eye medications: monitor for reduced antiviral efficacy.
  • Beta‑blocker eye drops: observe for intraocular pressure changes.

Frequently Asked Questions

Isopto-Maxidex is a dexamethasone ophthalmic suspension indicated for the treatment of postoperative ocular inflammation, uveitis, allergic conjunctivitis and other inflammatory eye conditions where a topical corticosteroid is required to control swelling, pain and redness.

Dexamethasone penetrates ocular tissues and binds intracellular glucocorticoid receptors. This binding modulates gene transcription, suppresses phospholipase A2, and reduces the synthesis of prostaglandins, leukotrienes and inflammatory cytokines, leading to decreased cellular inflammation and stabilisation of the ocular surface.

The dosing regimen for Isopto-Maxidex is determined by the prescribing clinician based on the specific indication, severity of inflammation and patient response. The prescriber will specify the number of drops, frequency and duration appropriate for each individual case.

Safety data for dexamethasone ophthalmic suspension in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and under medical supervision.

To order Isopto-Maxidex, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Isopto-Maxidex contains dexamethasone, a potent glucocorticoid with a rapid anti‑inflammatory effect. Compared with prednisolone acetate, dexamethasone generally offers a stronger potency per drop, allowing potentially lower dosing frequency, but both share similar safety profiles and require monitoring of intraocular pressure.

Store Isopto-Maxidex at room temperature, below 25 °C, in its original container. Protect the suspension from moisture and direct light. Keep the bottle tightly closed when not in use and discard any product that appears discoloured or contaminated.

Instill the prescribed number of drops into the affected eye(s) as directed by the prescriber, typically one to two drops per eye. Avoid touching the tip of the bottle to the eye or any surface. Remove contact lenses before administration and wait several minutes before reinserting them.

Serious risks include severe ocular hypertension or secondary glaucoma, which can lead to optic nerve damage, and rare cases of infectious keratitis or hypersensitivity reactions such as swelling, rash or anaphylaxis. Prompt ophthalmic evaluation is essential if these events occur.

Isopto-Maxidex is contraindicated in patients with known hypersensitivity to dexamethasone or any excipients in the formulation, and it should be avoided in eyes with active viral, fungal or bacterial infections unless the prescriber determines the benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dexamethasone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT